Watch Our Previous Sessions On Demand
The Future of Cell Therapies: An In-Depth Analysis of the 2023 Commercial and Research Landscape
Realizing the Full Potential within the RNA and Gene Therapy Landscapes: 2023 So Far
Gene Therapy: Optimizing the Safety of Viral Vectors
The ADC Boom: Navigating the Expansive Landscape of Antibody-Drug Conjugates
Bispecific Antibodies and Immune Checkpoint Modulators: A H1 Landscape Analysis
Examining the Cytokine-Based Drug Development Landscape: Interleukins and Beyond
Unlocking the Value of Microbiome-Targeting Therapeutics in Combating Infectious Diseases
T Cell Therapies: The Road Ahead for Addressing Autoimmune Indications
The TPD Disease Landscape: Oncology vs. Non-Oncology
The DDR Landscape: The Past, Present & Future
Additional Content
Beacon RNA: AACR Post-Conference Report 2024
Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization
Breaking Down AACR: A Comprehensive Review of DDR-Related Abstracts
Beacon DDR: AACR Pre-Conference Planner 2024
Decoding the Bivalent Degrader Landscape – Novel PROTACs, Developer Trends, and Future Innovations
Exploring the Synergy of ADCs in Combination with Checkpoints – A Comprehensive Review
The 2023 Checkpoint Landscape Review
The 2023 Bispecific Landscape Review
The 2023 DDR Landscape Review
The 2023 ADC Landscape Review
The 2023 Cytokine Landscape Review
The 2023 TPD Landscape Review
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
